In our study, all three scoring sytem successfully predicted the surgical complexity ve surgical outcomes and our results indicate that off-clamp PN has similar success and complications rates when compared to the literature. The off-clamp PN must be kept in mind to maintain postoperative renal functions eligible patients.
To evaluate the clinical findings, treatment methods and outcomes of patients treated for renal forniceal rupture (RFR). Materials and Methods: Files and records of the patients treated for RFR between January 2013 and November 2016 were evaluated retrospectively. In primary treatment; ureteroscopy and laser/pneumatic lithotripsy (URL) with stone fragmentation and double J (JJ) stent placement were performed in patients with no finding of sepsis. However, only JJ stent/percutaneous nephrostomy placement was performed in those with sepsis findings. The demographic characteristics, related symptoms, and the results of primary and secondary treatment of the patients were evaluated. Results: We had 43 patients with a mean age of 48.6±16.6 years. No cause was found in 4 patients while a urological cause was identified in 39 of them by using anamnesis, physical examination, laboratory and imaging methods. Out of 43 patients, percutaneous nephrostomy catheterization was performed in 5 of 32 patients under primary treatment. URL and JJ stenting were performed in the remaining 11 patients. Additionally, due to giant retroperitoneal urinoma, a retroperitoneal drain was placed in 2 patients by interventional radiology clinic. Conclusion: URL and stone fragmentation seem to be feasible treatment option in the primary treatment of patients with RFR without sepsis findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.